C$1.3 Million in Proceeds Received by The Precision Peptide Company from Warrant Exercises

Vancouver, British Columbia--(Newsfile Corp. - May 5, 2026) - The Precision Peptide Company (CSE: BPC) (OTCQB: PNGAF) (the "Company" or "BPC") a publicly traded wellness company focused on advanced peptide formulations and delivery systems, announces the receipt of approximately C$1.3 million from the exercise of outstanding warrants. The proceeds strengthen the Company's balance sheet and will be used to support the continued development and expansion of its Amino Innovations platform, including product rollout, delivery technology advancement, and distribution growth across North America.